Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/engineered-t-cells-that-express-both-cars-and-tcrs-can-better-distinguish-between-cancerous-and-healthy-tissues/
